Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 6/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.36 |
| ▸ | PRKACA | P17612 | 3/20 | 0.36 |
| ▸ | PRKG1 | Q13976 | 3/20 | 0.36 |
| ▸ | PRKACG | P22612 | 2/20 | 0.36 |
| ▸ | PRKACB | P22694 | 2/20 | 0.36 |
| ▸ | AKT1 | P31749 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 6/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23012235 | 0.92 | ROCK2 (0.40) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL29691382 | 0.92 | ROCK2 (0.40) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL29691431 | 0.91 | ROCK2 (0.41) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL23012385 | 0.91 | ROCK2 (0.41) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL23013492 | 0.81 | ROCK2 (0.45) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL21962108 | 0.80 | PKN1 (0.41) | CYP3A4NLRP3 | |
| SCHEMBL23012645 | 0.79 | CTSA (0.42) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL29691436 | 0.79 | CTSA (0.42) | ROCK2ROCK1PRKACAPRKG1PRKACG | |
| SCHEMBL21962081 | 0.79 | NLRP3 (0.46) | CYP3A4NLRP3LPAR1 | |
| SCHEMBL23012260 | 0.76 | SMN1; SMN2 (0.44) | ROCK2ROCK1PRKACAPRKG1PRKACG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013762-A1 | MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | Inflazome Limited (IE) | 2022-06-22 | — | — | EP | disclosed |